|
|
|
|
|
| (11) | Liudijimo numeris | C 3078743 |
| (68) | Patento numeris | 3078743 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2020 540 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2020-12-22 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2021-01-11 |
| Liudijimo paskelbimo data | 2022-06-10 | |
| (24) | Liudijimo įsigaliojimo data | 2028-09-27 |
| (71) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/18/1345, 2019-04-26 |
| (94) | 2033-09-26 |
| (95) | Andeksanetas alfa |
| PAL išduotas |